GC Biopharma녹십자
006280 · KOSPI · ₩006280 · 녹십자
Technical gauge
After the close on Oct 28, 2026Short term
Bullish
7 bullish, 0 neutral, 2 bearish
Medium term
Leaning bullish
5 bullish, 1 neutral, 2 bearish
What the indicators say
GC Biopharma closed at 130,500 won, sitting just above its 5-day (130,480 won) and 20-day (128,570 won) moving averages and above its 60-day (126,598.3 won) and 120-day (127,390 won) averages, while remaining well below its 200-day average (138,503 won). Short-term indicators lean bullish, with MACD above its signal line, RSI at 54.9, stochastic %K at 46.1 above %D at 50.2, and the price above the Ichimoku cloud, though trading volume is 0.6 times its 20-day average and OBV is trending down. Medium-term readings are leaning bullish, and ADX of 16.1 indicates a weak trend strength. Traders typically watch the support at 127,000 won and the resistance at 131,000 won, and the recent event log records a breakout above resistance on 2026-10-01 and again on 2026-10-06, the first such move in eight months, with the 2026-10-01 signal accompanied by 1.5 times normal volume.
Written by AI from the indicator values above. Not advice.
Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Squeeze! setup
1D timeframe- Entry
- ₩132,700
- Trailing STOP
- ₩123,600
- TPs
- ✅ ₩137,200₩141,800₩148,600₩155,400₩169,000
- DCA
- ₩130,400₩128,200₩125,900
- Peak profit
- +3.6%
- 1 of 5 targets hit
- 6d
Recent events
- Oct 23GC Biopharma · 🔥 Short squeeze joins the open LONG setup at 132,200 · 1D | -0.4%
- Oct 21GC Biopharma · 🔥 Short squeeze joins the open LONG setup at 131,400 · 1D | -1.0%
- Oct 21GC Biopharma · TP1 LONG ✅ : 137,200 · 1D | Peak profit +3.6%
- Oct 20Confirmed LONG 🔼 · GC Biopharma · Entry: 132,700 · 1D | Trailing STOP: 123,600 | TPs: 137,200 | 141,800 | 148,600 | 155,400 | 169,000 | DCA: 130,400 | 128,200 | 125,900 — after TP2 the trailing stop moves to the entry.
- Oct 19Ready to LONG 🔼 · GC Biopharma · Entry: 131,900 · 1D
Squeeze = Bollinger Bands (20, 2) inside Keltner Channels (20, 1.5) for 6+ bars; confirmed on a close beyond the squeeze range with momentum that way within 3 bars of the release. Stop 2 ATR, moved to the entry after TP2; targets 1 / 2 / 3.5 / 5 / 8 ATR; DCA 0.5 / 1 / 1.5 ATR. Paper-trading setup, not advice.
Chart
2026-10-28O 129,100H 132,700L 129,000C 130,500
Every indicator, chart overlays and the stock's recent technical events, with Pro.Unlock with Pro →
Indicators
- Moving averagesPrice above 4 of 5 averages5d ₩130,480 · 20d ₩128,570 · 60d ₩126,598 · 120d ₩127,390 · 200d ₩138,503Price above its averages is commonly read as an uptrend, below as a downtrend; the 200-day line is widely watched for the long-term trend.
- RSI (14)Upward momentum54.9Measures the speed of recent gains vs losses. Above 70 is often called overbought, below 30 oversold; extremes can last in strong trends.
- MACD (12, 26, 9)Above its signal line1,227 · signal 1,108 · histogram 119The gap between 12- and 26-day exponential averages. Crossing its signal line is read as momentum turning; above zero, the short-term average is above the long.
- Bollinger Bands (20, 2)Inside the bands₩123,203 – ₩128,570 – ₩133,937 · width 8.3%Bands two standard deviations around the 20-day average. A squeeze (very narrow bands) means unusually quiet trading, which often comes before a bigger move either way.
- Volume vs 20-day averageNormal trading0.63×Trading volume compared with its 20-day average. Moves on heavy volume are usually given more weight.
Every indicator, chart overlays and the stock's recent technical events, with Pro.
Unlock with ProTechnical events, last 90 days
Every indicator, chart overlays and the stock's recent technical events, with Pro.
Unlock with ProShort squeeze tracker
Score hidden
Sign in free to track one stock with the full squeeze tracker.
See the short squeeze score on your watchlist stocks with Pro.Unlock with Pro →or add Squeeze Pro (US$49/month) →
Estimates from short-selling data. Levels are not predictions or trading recommendations.
Share lending and returned shares
Shares lent out (mostly to short sellers), new loans and shares returned each day. A return is either the lender calling the shares back (a recall) or the borrower handing them back, often after buying back a short. The published figures don't say which.
- Shares on loan
- 469.8K
- 4% of listed shares
- Loans, 5-day change
- +2.2%
- Loans, 20-day change
- −0.3%
- Returned, last 5 days
- 27.3K
- New loans, last 5 days
- 37.6K
- Short balance vs loans
- 13.3%
- How much of the lent stock is sold short. The higher it is, the more buying back a wave of recalls forces.
Who's borrowing: foreign vs domestic
The shares on loan by who borrowed them and who lent them, by value.
- Foreign share, 5 days
- —
- Foreign share, 20 days
- —
- Foreign borrowing, 5 days
- —
As of Oct 27. Domestic borrowers include Korean brokers, some of which borrow for overseas clients, so this shows who holds the loan, not who finally sells short. Not a recommendation.
Unusual return days (last 60 days)
| Day | Returned | Of the loans | Vs usual |
|---|---|---|---|
| Oct 19 | 44.6K | 9.7% | 3.4× |
| Oct 7 | 36K | 7.5% | 3.5× |
| Oct 6 | 59.4K | 12.4% | 6.9× |
| Sep 22 | 26.5K | 5.4% | 3.9× |
| Sep 3 | 25.2K | 4.7% | 4× |
| Aug 26 | 29.4K | 6.3% | 4.7× |
Unusual = at least 3× the 20-day average, at least 2% of the shares on loan and 10,000 shares.
As of Oct 28. Published figures, one trading day behind. They describe lending, not where the price goes; not a recommendation.
Lending data: Financial Services Commission, Korea (Public Data Portal).
Retail margin & forced selling
Margin loans
₩30T
−7.3% in 5 days · 8th percentile of the last year
Forced selling
₩11B
0.4× the 20-day average
Forced-sale share
1.0%
Unpaid settlements
₩1T
Retail stock borrowing ₩21B
Calm under 30, normal to 50, elevated to 70, high above. From today's forced-sale amount vs its 20-day average, the forced-sale share of receivables, where margin loans sit in their 1-year range, and whether they are being cut fast.
Estimates from public margin-lending statistics. Not a prediction or a recommendation.
Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Also known as: GC Biopharma / 녹십자 / 006280 / KRX:006280
Source: KRX statistical information